Recombinant Human ALOX12

It is involved in the pathological process of virus-induced hepatitis, which may be related to virus clearance and liver disease recovery.

This is associated with some signaling pathways, such as PI3K/AKT pathway and MAPK pathway.

ALOX12 is involved in several biological processes associated with obesity, such as adipocyte differentiation, glucose and lipid metabolism.

ALOX12 is involved in the occurrence and development of a variety of neurodegenerative diseases, such as Parkinson's disease and Alzheimer's disease.

ALOX12 is involved in endothelial cell function impairment and is associated with diabetic complications.

This is a membrane binding protein with a core membrane binding domain and an extramembrane catalytic domain.

The oxidizes linolenic acid to produce 12S-LOX and 15S-LOX metabolites by oxygenation.

This protein is mainly involved in the metabolic pathway of linolenic acid, catalyzing the synthesis of 12S-LOX and 15S-LOX metabolites.

ALOX12 catalyzes linolenic acid to produce 12S-LOX and 15S-LOX metabolites, which have biological activities, including participating in inflammatory responses, regulating platelet activation, and regulating T cell function.

It is expressed in a variety of tissues in the human body, such as the skin, heart, lungs, liver, kidneys, intestines, and nervous system.

The human ALOX12 gene has a variety of variants, including SNP and InDel, that can lead to its dysfunction or increased risk.

ALOX12 is involved in the process of myocardial cell damage after myocardial infarction, which may be related to myocardial regeneration and repair.

ALOX12 is believed to be associated with a variety of diseases, such as cancer, inflammation, neurodegenerative diseases, cardiovascular disease, and more.